GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Pitavastatin Calcium

Company
Eccogene
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
14 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

14 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for Pitavastatin Calcium and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT05705804

    Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

    Not yet reported Yonsei University 250 participants Est. completion 2027-06-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT06001047

    Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV

    Not yet reported Xi'an No.3 Hospital 120 participants Est. completion 2026-11-01 1 site
    Other conditions: Benign Paroxysmal Positional Vertigo
    View official trial listing →
  • Recruiting NCT NCT06314919

    A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

    Boryung Pharmaceutical Co., Ltd 8606 participants Est. completion 2026-06 1 site
    Other conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia
    View official trial listing →
  • Recruiting NCT NCT06501443

    LATAM LOWERS LDL-C

    Not yet reported Novartis Pharmaceuticals 520 participants Est. completion 2026-11-29 11 sites
    Other conditions: Hypercholesterolaemia
    View official trial listing →
  • Recruiting NCT NCT06722521

    GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification

    Not yet reported Asan Medical Center 7435 participants Est. completion 2032-10-31 1 site Stand-alone
    Other conditions: Primary Prevention, Vascular Calcification
    View official trial listing →
  • Recruiting NCT NCT06767774

    Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

    Not yet reported Korea University Anam Hospital 2000 participants Est. completion 2030-01-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Diabetes, Statin
    View official trial listing →
  • Recruiting NCT NCT06858982

    PMMHRI-Pitavastatin Registry

    Polish Mother Memorial Hospital Research Institute 500 participants Est. completion 2028-12 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Recruiting NCT NCT07083206

    A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

    Ahn-Gook Pharmaceuticals Co.,Ltd 4500 participants Est. completion 2029-01 1 site
    Other conditions: Hypercholesterolemia, Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT07307989

    Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis

    Not yet reported Chang Gung Memorial Hospital 300 participants Est. completion 2029-07-31 1 site
    Cardiovascular disease Other conditions: Hypercholesteremia
    View official trial listing →
  • Recruiting NCT NCT07460960

    TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

    Not yet reported Lomonosov Moscow State University Medical Research and Educational Center 150 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction, Endothelial Dysfunction, Androgen Profile, Testosterone
    View official trial listing →
  • Recruiting NCT NCT07523971

    Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study

    JW Pharmaceutical 10000 participants Est. completion 2027-06 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Recruiting NCT NCT07524101

    Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

    Not yet reported Yonsei University 1952 participants Est. completion 2031-01-22 1 site Stand-alone
    Cardiovascular disease Other conditions: Renal Insufficiency, Atherosclerosis, Dyslipidemia, Hypercholesterolemia
    View official trial listing →
  • Recruiting NCT NCT07549958

    PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC)

    Not yet reported University of California, Irvine 18 participants Est. completion 2028-03-31 1 site Stand-alone
    Other conditions: Pancreatic Cancer, Pancreatic Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT07726368

    Study of ECC4703 With Sulfasalazine and Pitavastatin

    Not yet reported Eccogene 40 participants Est. completion 2026-12 1 site Stand-alone
    MASLD Other conditions: Dyslipidaemia
    View official trial listing →
  • Completed NCT NCT00242944

    Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)

    Not yet reported Kyoto University 307 participants Est. completion 2008-03 3 sites
    Other conditions: Coronary Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00249249

    Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels

    Not yet reported Kowa Research Europe 830 participants Est. completion 2006-11 192 sites
    Other conditions: Primary Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00257686

    Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients

    Not yet reported Kowa Research Europe 962 participants Est. completion 2006-05 62 sites Stand-alone
    Other conditions: Hypercholesterolemia or Combined Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00301392

    Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT)

    Not yet reported Tokyo University 1240 participants Est. completion 2012-06 1 site
    Other conditions: Diabetes Mellitus, Glucose Intolerance
    View official trial listing →
  • Completed NCT NCT00309738

    Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

    Not yet reported Kowa Research Europe 355 participants Est. completion 2006-10 35 sites Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00309751

    Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

    Not yet reported Kowa Research Europe 418 participants Est. completion 2007-06 35 sites Stand-alone
    Other conditions: Type II Diabetes Mellitus, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00309777

    Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

    Not yet reported Kowa Research Europe 857 participants Est. completion 2006-10 42 sites Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00325780

    Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

    Not yet reported Kowa Research Europe 1355 participants Est. completion 2007-11 186 sites Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00330876

    Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

    Not yet reported Kowa Research Europe 545 participants Est. completion 2007-12 59 sites Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT00344175

    Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors

    Not yet reported Kowa Research Europe 178 participants Est. completion 2007-08 28 sites Stand-alone
    Other conditions: Hypercholesterolemia, Dyslipidemia, Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00344370

    Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

    Not yet reported Kowa Research Europe 214 participants Est. completion 2008-04 35 sites Stand-alone
    Other conditions: Type II Diabetes Mellitus, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00444717

    Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome

    Not yet reported Aichi Gakuin University 100 participants Est. completion 2008-09 1 site
    Metabolic syndrome Other conditions: Oxidative Stress, Inflammation
    View official trial listing →
  • Terminated NCT NCT00548145

    The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease

    Not yet reported Osaka University 38 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Alzheimer Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00549926

    Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)

    Not yet reported Yokohama City University Medical Center 200 participants Est. completion 2010-02 1 site
    Other conditions: Coronary Disease, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00640276

    Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome

    Not yet reported JW Pharmaceutical 187 participants Est. completion 2011-06 2 sites
    Metabolic syndrome Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00653913

    Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)

    Not yet reported Organon and Co 18 participants Est. completion 2004-09
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00701285

    South Korean Pitavastatin Heart Failure Study

    Not yet reported JW Pharmaceutical 70 participants Est. completion 2014-05 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT00711919

    Pitavastatin on Carotid Intima-media Thickness

    Not yet reported Kyoto Prefectural University of Medicine 300 participants 18 sites
    Other conditions: Hyperlipidemia, Carotid Artery Diseases
    View official trial listing →
  • Completed NCT NCT00716846

    Effects of Statins on the Pharmacokinetics for Midazolam in Healthy Volunteers

    Not yet reported Hamamatsu University 11 participants Est. completion 2008-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00723398

    Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention

    Not yet reported Milton S. Hershey Medical Center 266 participants Est. completion 2015-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00786734

    Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA)

    Not yet reported JW Pharmaceutical Est. completion 2010-07 1 site Stand-alone
    Other conditions: Percutaneous Coronary Intervention
    View official trial listing →
  • Completed NCT NCT00805714

    Livalo Acute Myocardial Infarction Study

    JW Pharmaceutical 1128 participants Est. completion 2011-03 10 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00846118

    Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)

    Not yet reported Chieko Hamada 905 participants Est. completion 2014-09-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00861861

    Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD)

    Not yet reported Kumamoto University 129 participants Est. completion 2013-10 1 site
    Cardiovascular disease Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00889226

    Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia

    Not yet reported JW Pharmaceutical 161 participants Est. completion 2010-01 Stand-alone
    Other conditions: Hypercholesterolemia With Type2DM
    View official trial listing →
  • Completed NCT NCT01042730

    Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)

    Not yet reported Juntendo University 13054 participants Est. completion 2017-11 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01043094

    Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers

    Not yet reported Kowa Research Institute, Inc. 16 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Severe Renal Impairment
    View official trial listing →
  • Completed NCT NCT01057433

    Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin

    Not yet reported Kowa Research Institute, Inc. 24 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01166633

    Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia

    Not yet reported JW Pharmaceutical 200 participants Est. completion 2011-02 Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01178853

    Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

    Not yet reported Kowa Research Institute, Inc. 48 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01223586

    Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome

    Kyoto University 238 participants Est. completion 2011-05 2 sites
    Other conditions: Statin, Coronary Plaque, Acute Coronary Syndrome, Intravascular Ultrasound, Cardiovascular Events
    View official trial listing →
  • Completed NCT NCT01232049

    Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101)

    Not yet reported Asan Medical Center 24 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01256476

    Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia

    Not yet reported Kowa Research Institute, Inc. 328 participants Est. completion 2011-06 44 sites Stand-alone
    Other conditions: Primary Dyslipidemia, Mixed Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01265706

    Livalo Acute Myocardial Infarction Study (LAMIS)

    JW Pharmaceutical 1000 participants Est. completion 2014-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01301066

    A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects

    Not yet reported Kowa Research Institute, Inc. 252 participants Est. completion 2013-03 35 sites Stand-alone
    Other conditions: Dyslipidemia
    View official trial listing →
  • Status unknown NCT NCT01386853

    Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients

    Not yet reported Tai Tien Pharmaceuticals Co., Ltd. 200 participants Est. completion 2012-07 6 sites Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01402843

    Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia

    Not yet reported JW Pharmaceutical 150 participants Est. completion 2013-01 10 sites Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01406431

    Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

    Not yet reported JW Pharmaceutical 48 participants Est. completion 2012-10 1 site
    Other conditions: Hyperlipidemia, Hypertension
    View official trial listing →
  • Completed NCT NCT01422369

    Drug-Drug Interaction of Darunavir/Ritonavir on Pitavastatin

    Not yet reported Kowa Research Institute, Inc. 28 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01422382

    Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin

    Not yet reported Kowa Research Institute, Inc. 28 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01502904

    Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

    Not yet reported Yonsei University 120 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension
    View official trial listing →
  • Completed NCT NCT01595828

    Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome

    Not yet reported Kowa Research Europe 14 participants Est. completion 2012-06 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Status unknown NCT NCT01648829

    PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity

    Not yet reported University of Roma La Sapienza 100 participants Est. completion 2017-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01660191

    A Study Comparing CoQ10 Levels While Taking 3 Different Statins

    Not yet reported University of Kansas Medical Center 134 participants Est. completion 2013-10 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01695954

    Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz

    Not yet reported NYU Langone Health 34 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Hyperlipidemia, HIV
    View official trial listing →
  • Completed NCT NCT01710007

    Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia

    Not yet reported Orient Pharma Co., Ltd. 202 participants Est. completion 2012-11 8 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT01764178

    To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

    Not yet reported JW Pharmaceutical 52 participants Est. completion 2013-12-27 1 site Stand-alone
    Other conditions: Hyperlipidemia, Hypertension
    View official trial listing →
  • Completed NCT NCT01767610

    Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin

    Not yet reported Hanlim Pharm. Co., Ltd. 24 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Healthy Male Volunteers
    View official trial listing →
  • Status unknown NCT NCT01871792

    Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction

    Not yet reported Gachon University Gil Medical Center 404 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Contrast-induced Nephropathy
    View official trial listing →
  • Completed NCT NCT01890967

    A Study of LY3015014 in Participants With High Cholesterol

    Not yet reported Eli Lilly and Company 527 participants Est. completion 2014-06 49 sites
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02056847

    to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia

    Not yet reported JW Pharmaceutical 313 participants Est. completion 2017-05 1 site
    Other conditions: HbA1c Level Associated With Lipid Compositions
    View official trial listing →
  • Completed NCT NCT02107898

    Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)

    Not yet reported Sanofi 216 participants Est. completion 2015-09 32 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT02144922

    Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients

    Not yet reported Asan Medical Center 85 participants Est. completion 2016-10 1 site
    Other conditions: Hypertension, Cardiovascular Risk
    View official trial listing →
  • Completed NCT NCT02250976

    The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca

    Not yet reported Hanlim Pharm. Co., Ltd. 41 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Healthy Male Volunteers
    View official trial listing →
  • Completed NCT NCT02290106

    Effects of Pitavastatin on Insulin Sensitivity and Liver Fat

    Not yet reported Massachusetts General Hospital 50 participants Est. completion 2018-04-30 1 site Stand-alone
    Other conditions: Obesity, Fatty Liver, Nonalcoholic
    View official trial listing →
  • Completed NCT NCT02344290

    Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 7769 participants Est. completion 2023-08-21 137 sites Stand-alone
    Cardiovascular disease Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02442700

    Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir

    Not yet reported Ramathibodi Hospital 24 participants Est. completion 2015-01 Stand-alone
    Other conditions: HIV, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02545231

    Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis

    Not yet reported Korea University Anam Hospital 1000 participants Est. completion 2020-08 1 site
    Other conditions: Atherosclerosis, Neointima, Angina
    View official trial listing →
  • Completed NCT NCT02595268

    A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 14 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02634034

    A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers

    Not yet reported Kowa Research Institute, Inc. 18 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Withdrawn NCT NCT02670434

    Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia

    Not yet reported Kowa Research Institute, Inc. Est. completion 2017-10 45 sites
    Other conditions: Hyperlipidemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02743260

    Drug Transporter Interaction Study PHENTRA_2015_KPUK

    Not yet reported University of Cologne 24 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT02799758

    Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia

    Not yet reported Kowa Research Institute, Inc. Est. completion 2017-11 69 sites
    Other conditions: Hyperlipidemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02863185

    Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease

    Not yet reported Dong-A University 45 participants Est. completion 2020-12-31 2 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02888327

    A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872

    Not yet reported Alios Biopharma Inc. 68 participants Est. completion 2017-05-30 1 site
    Other conditions: Influenza in Humans
    View official trial listing →
  • Status unknown NCT NCT02940366

    Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome

    Not yet reported Seoul National University Hospital 500 participants Est. completion 2019-11-30 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02956590

    Dyslipidemia of Obesity Intervention in Teens

    Not yet reported Carelon Research 122 participants Est. completion 2023-06-30 16 sites
    Other conditions: Dyslipidemia, Obesity
    View official trial listing →
  • Completed NCT NCT03070223

    PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332)

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 602 participants Est. completion 2023-08-21 31 sites Stand-alone
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT03311841

    Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)

    Not yet reported Merck Sharp & Dohme LLC 32 participants Est. completion 2018-08-02 2 sites Stand-alone
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Status unknown NCT NCT03418974

    Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia

    Not yet reported Fudan University 10000 participants Est. completion 2021-12-31 2 sites Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT03532620

    China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension

    Not yet reported Jun Tao 396 participants Est. completion 2020-09 13 sites Stand-alone
    Other conditions: Prediabetic State, Hypertension, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT03606824

    Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)

    Not yet reported Shaochun.Li 248 participants Est. completion 2020-05-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemia, Subclinical hypothyroïdism, Statin
    View official trial listing →
  • Completed NCT NCT03618797

    A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

    Not yet reported Hanlim Pharm. Co., Ltd. 347 participants Est. completion 2018-05 Stand-alone
    Other conditions: Complex-dyslipidemia
    View official trial listing →
  • Completed NCT NCT03717064

    A Study to Investigate the Effect of RO7049389 on the Pharmacokinetics of Pitavastatin in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 18 participants Est. completion 2018-12-17 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03730038

    Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With Dyslipidemia

    Not yet reported Yonsei University 50 participants Est. completion 2020-02-13 1 site Stand-alone
    Other conditions: Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04061824

    Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

    Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04270344

    The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment

    JW Pharmaceutical 905 participants Est. completion 2022-06-30 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04289649

    K-924 Phase III Confirmatory Study

    Not yet reported Kowa Company, Ltd. 293 participants Est. completion 2020-11-21 3 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04289662

    K-924 Phase III Long Term Study

    Not yet reported Kowa Company, Ltd. 110 participants Est. completion 2021-08-07 13 sites Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04402112

    Efficacy and Safety of Pitavastatin in a Real-world Setting

    JW Pharmaceutical 28343 participants Est. completion 2017-08-01
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04512105

    Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

    Not yet reported University of California, Irvine 6 participants Est. completion 2025-02-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, AML, Adult, CLL, CLL, Relapsed, CLL, Refractory
    View official trial listing →
  • Completed NCT NCT04584736

    To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

    Not yet reported JW Pharmaceutical 283 participants Est. completion 2020-10-12 1 site Stand-alone
    Other conditions: Primary Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04643093

    Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

    Not yet reported Orient Pharma Co., Ltd. 390 participants Est. completion 2021-10-05 34 sites
    Other conditions: Primary Hypercholesterolemia, Mixed Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04705909

    Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer

    Not yet reported, Not yet reported Mansoura University 60 participants Est. completion 2021-12-15 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04764851

    Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates

    Not yet reported Emalex Biosciences Inc. 30 participants Est. completion 2021-05-07 1 site
    Other conditions: Drug-Interactions
    View official trial listing →
  • Completed NCT NCT04829149

    Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

    Hanmi Pharmaceutical Company Limited 5717 participants Est. completion 2019-08-29 1 site
    Other conditions: Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04945122

    Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 900 participants Est. completion 2023-12-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Glucose Metabolism Disorders
    View official trial listing →
  • Completed NCT NCT05285085

    Real World Evidence Study of Statin Use in Brazil

    Hospital Israelita Albert Einstein 2133900 participants Est. completion 2021-12-15 1 site
    Cardiovascular disease Other conditions: Hypertension, Diabetes Mellitus, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT05334108

    Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport

    Not yet reported Emalex Biosciences Inc. 56 participants Est. completion 2022-08-26 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Active, not recruiting NCT NCT05537948

    Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients

    Not yet reported National Medical Research Center for Therapy and Preventive Medicine 59 participants Est. completion 2025-01-31 1 site
    Other conditions: Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder, Immunosuppression, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Statins
    View official trial listing →
  • Status unknown NCT NCT05747768

    A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients

    Not yet reported Peking University Third Hospital 60 participants Est. completion 2024-12-31 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT05977738

    Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin

    Not yet reported C.Dirven 12 participants Est. completion 2024-07-19 1 site Stand-alone
    Other conditions: Glioblastoma Multiforme, Adult, Recurrent Glioblastoma
    View official trial listing →
  • Not yet recruiting NCT NCT06096909

    Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population

    Not yet reported China National Center for Cardiovascular Diseases 3684 participants Est. completion 2027-11-01 Stand-alone
    Other conditions: Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT06262685

    Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins

    Not yet reported Instituto de Investigación Hospital Universitario La Paz 216 participants Est. completion 2025-03-04 1 site Stand-alone
    Cardiovascular disease Other conditions: Dyslipidemias, Statin Adverse Reaction, Pharmacogenic Myopathy
    View official trial listing →
  • Status unknown NCT NCT06273215

    Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients

    Not yet reported Peking University Third Hospital 48 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT06317051

    Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)

    Not yet reported Kirby Institute 300 participants Est. completion 2027-12 10 sites
    Other conditions: HIV Infections, Weight Gain
    View official trial listing →
  • Completed NCT NCT06359353

    Effect of Pitavastatin on Bone

    Not yet reported Seoul National University Bundang Hospital 70 participants Est. completion 2023-12-19 1 site Stand-alone
    Other conditions: Osteoporosis, Osteopenia, Hypercholesterolemia, Menopausal Osteoporosis
    View official trial listing →
  • Completed NCT NCT06553157

    Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

    Not yet reported, Not yet reported Minia University 56 participants Est. completion 2025-10-01 1 site Stand-alone
    Other conditions: Solid Tumors, Ototoxicity
    View official trial listing →
  • Completed NCT NCT06808646

    A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin

    Not yet reported Basilea Pharmaceutica 12 participants Est. completion 2025-02-25 1 site Stand-alone
    Other conditions: Drug-drug Interaction Study
    View official trial listing →
  • Completed NCT NCT06813924

    A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants

    Not yet reported Novo Nordisk A/S 37 participants Est. completion 2025-05-27 1 site Stand-alone
    Other conditions: Healthy Volunteers Sickle Cell Disease, Thalassemia
    View official trial listing →
  • Active, not recruiting NCT NCT06982131

    A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

    Not yet reported Hoffmann-La Roche 40 participants Est. completion 2026-12-07 1 site Stand-alone
    Other conditions: Overweight, Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT07351565

    Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer

    Not yet reported Chang Chen 22 participants Est. completion 2026-12-31 Stand-alone
    Other conditions: Non-Small Cell Lung Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07442630

    Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

    Not yet reported JW Pharmaceutical 88 participants Est. completion 2026-11-30 1 site Stand-alone
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT07445542

    Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia

    JW Pharmaceutical 6927 participants Est. completion 2025-05-13 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT07567781

    A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

    Not yet reported AbbVie 12 participants Est. completion 2026-07-21 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT07626840

    Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

    Not yet reported Samsung Medical Center 5000 participants Est. completion 2031-12-31 Stand-alone
    Other conditions: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
    View official trial listing →
  • Not yet recruiting NCT NCT07774975

    Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis Pigmentosa

    Not yet reported Kyushu University 21 participants Est. completion 2028-03-31 Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Not yet recruiting NCT NCT07784621

    A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults

    Not yet reported Huons Co., Ltd. 30 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Pitavastatin Calcium, Pitavastatin

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.